{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:05:10Z","timestamp":1759730710143},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T00:00:00Z","timestamp":1332374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10549-012-2022-8","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T16:27:05Z","timestamp":1332433625000},"page":"1189-1197","source":"Crossref","is-referenced-by-count":19,"title":["Accuracy of BRCA1\/2 mutation prediction models in Korean breast cancer patients"],"prefix":"10.1007","volume":"134","author":[{"name":"Korean Breast Cancer Society","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunyoung","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue K.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Jeong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,22]]},"reference":[{"issue":"5","key":"2022_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2022_CR2","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701\u20132712","journal-title":"J Clin Oncol"},{"issue":"29","key":"2022_CR3","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2006.10.4703","volume":"25","author":"KJ Vogel","year":"2007","unstructured":"Vogel KJ, Atchley DP, Erlichman J, Broglio KR, Ready KJ, Valero V, Amos CI, Hortobagyi GN, Lu KH, Arun B (2007) BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25(29):4635\u20134641. doi: 10.1200\/JCO.2006.10.4703","journal-title":"J Clin Oncol"},{"issue":"8","key":"2022_CR4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1200\/JCO.2008.17.5869","volume":"27","author":"D Huo","year":"2009","unstructured":"Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 27(8):1184\u20131190. doi: 10.1200\/JCO.2008.17.5869","journal-title":"J Clin Oncol"},{"issue":"2","key":"2022_CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10689-009-9305-1","volume":"9","author":"JJ Harssel van","year":"2010","unstructured":"van Harssel JJ, van Roozendaal CE, Detisch Y, Brandao RD, Paulussen AD, Zeegers M, Blok MJ, Gomez Garcia EB (2010) Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1\/2 mutation detection. Fam Cancer 9(2):193\u2013201. doi: 10.1007\/s10689-009-9305-1","journal-title":"Fam Cancer"},{"issue":"29","key":"2022_CR6","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1200\/JCO.2008.16.8310","volume":"26","author":"AW Kurian","year":"2008","unstructured":"Kurian AW, Gong GD, Chun NM, Mills MA, Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, Ridge Y, Panabaker K, West DW, Whittemore AS, Ford JM (2008) Performance of BRCA1\/2 mutation prediction models in Asian Americans. J Clin Oncol 26(29):4752\u20134758. doi: 10.1200\/JCO.2008.16.8310","journal-title":"J Clin Oncol"},{"issue":"5","key":"2022_CR7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jso.21110","volume":"98","author":"SS Ko","year":"2008","unstructured":"Ko SS (2008) Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10\u00a0years (1996\u20132006) using nationwide breast cancer registration on-line program: biannual update. J Surg Oncol 98(5):318\u2013323. doi: 10.1002\/jso.21110","journal-title":"J Surg Oncol"},{"issue":"4","key":"2022_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4048\/jbc.2010.13.4.418","volume":"13","author":"E Kang","year":"2010","unstructured":"Kang E, Ahn SH, Noh WC, Noh DY, Jung Y, Kim LS, Choi DH, Suh YJ, Kim KS, Lee JE, Lee MH, Nam SJ, Moon BI, Son BH, Yang JH, Yom CK, Kim SY, Park SK, Kim SW (2010) The KOHBRA study has changed the practice patterns for managing hereditary breast cancer in Korea. J Breast Cancer 13(4):351\u2013356","journal-title":"J Breast Cancer"},{"issue":"4","key":"2022_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4048\/jbc.2007.10.4.241","volume":"10","author":"EK Kim","year":"2007","unstructured":"Kim EK, Kim KS, Park SK, Ahn SH, Lee MH, Kim SW, Korean Breast Cancer Society (2007) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocol rewiew. J Breast Cancer 10(4):241\u2013247","journal-title":"J Breast Cancer"},{"issue":"7","key":"2022_CR10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clon.2010.11.007","volume":"23","author":"SA Han","year":"2011","unstructured":"Han SA, Park SK, Hyun Ahn S, Hyuk Lee M, Noh DY, Kim LS, Noh WC, Jung Y, Sang Kim K, Kim SW, Korean Breast Cancer Study Group (2011) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and interim report. Clin Oncol (R Coll Radiol) 23(7):434\u2013441. doi: 10.1016\/j.clon.2010.11.007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2022_CR11","doi-asserted-by":"crossref","unstructured":"Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22(9):1638\u20131645. doi: 10.1200\/JCO.2004.04.179 JCO.2004.04.179","DOI":"10.1200\/JCO.2004.04.179"},{"issue":"7","key":"2022_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PD (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425\u2013431. doi: 10.1136\/jmg.2007.056556","journal-title":"J Med Genet"},{"key":"2022_CR13","doi-asserted-by":"crossref","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145\u2013158","DOI":"10.1086\/301670"},{"issue":"6","key":"2022_CR14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490","journal-title":"J Clin Oncol"},{"key":"2022_CR15","doi-asserted-by":"crossref","unstructured":"Parmigiani G, Chen S, Iversen ES, Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147(7):441\u2013450","DOI":"10.7326\/0003-4819-147-7-200710020-00002"},{"issue":"4","key":"2022_CR16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1055-9965.EPI-08-1090","volume":"18","author":"AW Kurian","year":"2009","unstructured":"Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, West DW, Whittemore AS (2009) Performance of prediction models for BRCA mutation carriage in three racial\/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 18(4):1084\u20131091. doi: 10.1158\/1055-9965.EPI-08-1090","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"15","key":"2022_CR17","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","volume":"294","author":"R Nanda","year":"2005","unstructured":"Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925\u20131933. doi: 10.1001\/jama.294.15.1925","journal-title":"JAMA"},{"issue":"3","key":"2022_CR18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-008-9965-9","volume":"113","author":"NY Rao","year":"2009","unstructured":"Rao NY, Hu Z, Li WF, Huang J, Ma ZL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM (2009) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and\/or ovarian cancer patients. Breast Cancer Res Treat 113(3):467\u2013477. doi: 10.1007\/s10549-008-9965-9","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"2022_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.10154","volume":"20","author":"A Liede","year":"2002","unstructured":"Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20(6):413\u2013424. doi: 10.1002\/humu.10154","journal-title":"Hum Mutat"},{"issue":"3","key":"2022_CR20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4048\/jbc.2011.14.3.229","volume":"14","author":"YS Jung","year":"2011","unstructured":"Jung YS, Na KY, Kim KS, Ahn SH, Lee SJ, Park HK, Cho YU (2011) Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer 14(3):229\u2013236. doi: 10.4048\/jbc.2011.14.3.229","journal-title":"J Breast Cancer"},{"key":"2022_CR21","unstructured":"Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (2010) SEER Cancer Statistics Review 1975\u20132008. National Cancer Institute. http:\/\/seer.cancer.gov\/csr\/1975_2008\/ . Accessed 7 September 2011"},{"issue":"1","key":"2022_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.epirev.a036118","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15(1):7\u201316","journal-title":"Epidemiol Rev"},{"issue":"23","key":"2022_CR23","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","volume":"297","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ, MacDonald DJ (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587\u20132595. doi: 10.1001\/jama.297.23.2587","journal-title":"JAMA"},{"key":"2022_CR24","unstructured":"American Society of Clinical Oncology (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol. 14 (5):1730\u20131736; discussion 1737\u20131740"},{"issue":"4","key":"2022_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10689-009-9279-z","volume":"8","author":"MW Seong","year":"2009","unstructured":"Seong MW, Cho SI, Noh DY, Han W, Kim SW, Park CM, Park HW, Kim SY, Kim JY, Park SS (2009) Low contribution of BRCA1\/2 genomic rearrangement to high-risk breast cancer in the Korean population. Fam Cancer 8(4):505\u2013508. doi: 10.1007\/s10689-009-9279-z","journal-title":"Fam Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2022-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2022-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T19:08:32Z","timestamp":1561489712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2022-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,22]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2022-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2012,3,22]]}}}